Szeremeta, A.; Jura-Półtorak, A.; Zoń-Giebel, A.; Olczyk, K.; Komosińska-Vassev, K.
Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid Arthritis. J. Clin. Med. 2023, 12, 5185.
https://doi.org/10.3390/jcm12165185
AMA Style
Szeremeta A, Jura-Półtorak A, Zoń-Giebel A, Olczyk K, Komosińska-Vassev K.
Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid Arthritis. Journal of Clinical Medicine. 2023; 12(16):5185.
https://doi.org/10.3390/jcm12165185
Chicago/Turabian Style
Szeremeta, Anna, Agnieszka Jura-Półtorak, Aleksandra Zoń-Giebel, Krystyna Olczyk, and Katarzyna Komosińska-Vassev.
2023. "Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid Arthritis" Journal of Clinical Medicine 12, no. 16: 5185.
https://doi.org/10.3390/jcm12165185
APA Style
Szeremeta, A., Jura-Półtorak, A., Zoń-Giebel, A., Olczyk, K., & Komosińska-Vassev, K.
(2023). Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid Arthritis. Journal of Clinical Medicine, 12(16), 5185.
https://doi.org/10.3390/jcm12165185